North
The number of attempts remaining is 1
1 / 12
According to WHO, chronic obstructive pulmonary disease (COPD) is the ___________ leading cause of death worldwide, causing 3.23 million deaths in 2019
2 / 12
The most prescribed LAMA in USA is ___________
3 / 12
As per GOLD guidelines 2023, COPD as been defined as ___________ lung condition characterized by chronic respiratory symptoms
4 / 12
As per GOLD Guidelines 2023, COPD-G has been defined as genetically determined COPD where as COPD-L has been defined as COPD due to abnormal lung development
5 / 12
The initial pharmacological treatment chart in GOLD Guidelines 2023 comprises of 3 segments namely A,B and E in which:
6 / 12
Clinical Trials have shown a greater effect on exacerbation rates for (as mentioned in GOLD guidelines):
7 / 12
In a large, long-term clinical trial in COPD patients, ___________ added to other standard therapies had no effect on cardiovascular risk (as mentioned in GOLD guidelines)
8 / 12
Long-acting muscarinic antagonists, predominately ___________ and ___________ can improve sputum production and decrease cough in patients with moderate to severe COPD (as mentioned in GOLD guidelines)
9 / 12
GINA guidelines 2022 recommend using ___________ as an add on treatment for Asthmatic patients falling in STEP-5
10 / 12
GINA guidelines 2022 also mention that for patients falling in STEP-4, LAMA maybe considered as add-on therapy in separate inhalers for patients aged 6 years and above (tiotropium) or in combination (triple) inhaler for patients aged 18 years and above
11 / 12
What is the name of the first tiotropium launched in Pakistan?
12 / 12
What is the name of the first LABA + LAMA combination launched in Pakistan?
Your score is
